Related references
Note: Only part of the references are listed.Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical and microbiological evaluation of hemodialysis-associated pneumonia (HDAP): should HDAP be included in healthcare-associated pneumonia?
Satoshi Kawasaki et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2011)
Relationship of Vancomycin Minimum Inhibitory Concentration to Mortality in Patients With Methicillin-Resistant Staphylococcus aureus Hospital-Acquired, Ventilator-Associated, or Health-care-Associated Pneumonia
Nadia Z. Hague et al.
CHEST (2010)
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis
Andre C. Kalil et al.
CRITICAL CARE MEDICINE (2010)
Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models
Moliere Nguile-Makao et al.
INTENSIVE CARE MEDICINE (2010)
Health Care-Associated Invasive MRSA Infections, 2005-2008
Alexander J. Kallen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2009)
Pneumonia caused by methicillin-resistant Staphylococcus aureus
Ethan Rubinstein et al.
CLINICAL INFECTIOUS DISEASES (2008)
Health care-associated pneumonia and community-acquired pneumonia: A single-center experience
Scott T. Micek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003
RM Klevens et al.
CLINICAL INFECTIOUS DISEASES (2006)
Epidemiology and outcomes of health-care-associated pneumonia - Results from a large US database of culture-positive pneumonia
MH Kollef et al.
CHEST (2005)
Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides
J Rello et al.
CRITICAL CARE MEDICINE (2005)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin
MH Kollef et al.
INTENSIVE CARE MEDICINE (2004)
Drotrecogin alfa (activated) improves in-hospital and 90-day survival in patients with severe sepsis and community-acquired pneumonia
RG Wunderink et al.
CHEST (2003)
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia
RG Wunderink et al.
CLINICAL THERAPEUTICS (2003)
Linezolid vs vancomycin - Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia
RG Wunderink et al.
CHEST (2003)
Ventilator-associated pneumonia
J Chastre et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenter study
E Rubinstein et al.
CLINICAL INFECTIOUS DISEASES (2001)